[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fOJiaCTXkfOz7lJw9x7_qcgbZ5yga6QaoNYcZSBAHKlc":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":8,"truncated":9,"activeTrials":10,"phase3Count":11,"totalEnrollment":12,"activePrograms":13,"nonDrugCount":14,"topConditions":15,"upcomingReadouts":39,"phaseBuckets":50,"rows":57},"University of Toronto",[4,6,7],"University of Toronto Practice Based Research Network","University of Toronto Orthopaedic Sports Medicine",402,false,53,21,711466,3,372,[16,19,22,25,28,31,34,37],{"name":17,"count":18},"Obesity",37,{"name":20,"count":21},"Diabetes",29,{"name":23,"count":24},"Cardiovascular Diseases",25,{"name":26,"count":27},"Healthy",20,{"name":29,"count":30},"Hypertension",19,{"name":32,"count":33},"Metabolic Syndrome",15,{"name":35,"count":36},"Type 2 Diabetes",12,{"name":38,"count":36},"Stroke",[40,45],{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT07050277","Post-Operative Urinary Retention on Revision Knee Arthroplasty: the Role of Intrathecal Morphine","2027-07-01","Intrathecal Morphine",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT06823596","The T Cell Activator of Cell Killing (\"TACK\") IT ON\" STUDY","2027-11-15","Efavirenz 600mg",[51,52,53,54,55,56],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[58,87,105,127,166,194,212,230,257,275,300,325,352,370,388,414,439,463,492,518,536,562,580,608,626,644,662,688,714,732,758,776,802,827,855,873,891,909,933,957,975,1003,1021,1047,1072,1100,1118,1144,1162,1180],{"intervention":44,"totalTrials":59,"cells":60},1,{"EARLY_PHASE1":61,"PHASE1":64,"PHASE2":66,"PHASE3":68,"PHASE4":83,"NA":85},{"trials":62,"activeCount":63},[],0,{"trials":65,"activeCount":63},[],{"trials":67,"activeCount":63},[],{"trials":69,"activeCount":59,"soonestReadout":43},[70],{"nctId":41,"briefTitle":42,"status":71,"phases":72,"primaryCompletion":43,"completion":73,"start":74,"enrollment":75,"conditions":76,"interventions":81},"RECRUITING",[54],"2027-08-01","2025-06-24",50,[77,78,79,80],"Arthroplasties, Knee Replacement","Nerve Block","Urinary Retention Postoperative","Anesthesia, Spinal",[44,82],"No Intrathecal Morphine",{"trials":84,"activeCount":63},[],{"trials":86,"activeCount":63},[],{"intervention":82,"totalTrials":59,"cells":88},{"EARLY_PHASE1":89,"PHASE1":91,"PHASE2":93,"PHASE3":95,"PHASE4":101,"NA":103},{"trials":90,"activeCount":63},[],{"trials":92,"activeCount":63},[],{"trials":94,"activeCount":63},[],{"trials":96,"activeCount":59,"soonestReadout":43},[97],{"nctId":41,"briefTitle":42,"status":71,"phases":98,"primaryCompletion":43,"completion":73,"start":74,"enrollment":75,"conditions":99,"interventions":100},[54],[77,78,79,80],[44,82],{"trials":102,"activeCount":63},[],{"trials":104,"activeCount":63},[],{"intervention":49,"totalTrials":59,"cells":106},{"EARLY_PHASE1":107,"PHASE1":109,"PHASE2":111,"PHASE3":113,"PHASE4":115,"NA":117},{"trials":108,"activeCount":63},[],{"trials":110,"activeCount":63},[],{"trials":112,"activeCount":63},[],{"trials":114,"activeCount":63},[],{"trials":116,"activeCount":63},[],{"trials":118,"activeCount":59,"soonestReadout":48},[119],{"nctId":46,"briefTitle":47,"status":71,"phases":120,"primaryCompletion":48,"completion":121,"start":122,"enrollment":123,"conditions":124,"interventions":126},[56],"2028-11-15","2025-01-14",26,[125],"Hiv",[49],{"intervention":128,"totalTrials":129,"cells":130},"Saline",2,{"EARLY_PHASE1":131,"PHASE1":133,"PHASE2":135,"PHASE3":137,"PHASE4":139,"NA":164},{"trials":132,"activeCount":63},[],{"trials":134,"activeCount":63},[],{"trials":136,"activeCount":63},[],{"trials":138,"activeCount":63},[],{"trials":140,"activeCount":63},[141,153],{"nctId":142,"briefTitle":143,"status":144,"phases":145,"primaryCompletion":146,"completion":147,"start":148,"enrollment":63,"conditions":149,"interventions":151},"NCT01272414","Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction","WITHDRAWN",[55],"2012-01","2012-02","2011-01",[150],"Graves Ophthalmopathy",[152,128],"Botulinum Toxin Type A",{"nctId":154,"briefTitle":155,"status":144,"phases":156,"primaryCompletion":157,"completion":158,"start":159,"enrollment":63,"conditions":160,"interventions":162},"NCT01326585","Study Trial of Dexamethasone Use for Alleviation of Symptoms After Scleral Buckle Eye Surgery",[55],"2012-03","2012-04","2011-04",[161],"Retinal Detachment",[163,128],"Dexamethasone Sodium Phosphate",{"trials":165,"activeCount":63},[],{"intervention":167,"totalTrials":59,"cells":168},"10% intravenous immunoglobulin",{"EARLY_PHASE1":169,"PHASE1":171,"PHASE2":173,"PHASE3":175,"PHASE4":177,"NA":192},{"trials":170,"activeCount":63},[],{"trials":172,"activeCount":63},[],{"trials":174,"activeCount":63},[],{"trials":176,"activeCount":63},[],{"trials":178,"activeCount":63},[179],{"nctId":180,"briefTitle":181,"status":182,"phases":183,"primaryCompletion":184,"completion":184,"start":185,"enrollment":24,"conditions":186,"interventions":190},"NCT02372149","IVIg for Demyelination in Diabetes Mellitus","UNKNOWN",[55],"2018-02","2015-02",[187,188,189],"Peripheral Neuropathy","Diabetes Mellitus","Chronic Inflammatory Demyelinating Polyneuropathy",[167,191],"0.9% sodium chloride",{"trials":193,"activeCount":63},[],{"intervention":191,"totalTrials":59,"cells":195},{"EARLY_PHASE1":196,"PHASE1":198,"PHASE2":200,"PHASE3":202,"PHASE4":204,"NA":210},{"trials":197,"activeCount":63},[],{"trials":199,"activeCount":63},[],{"trials":201,"activeCount":63},[],{"trials":203,"activeCount":63},[],{"trials":205,"activeCount":63},[206],{"nctId":180,"briefTitle":181,"status":182,"phases":207,"primaryCompletion":184,"completion":184,"start":185,"enrollment":24,"conditions":208,"interventions":209},[55],[187,188,189],[167,191],{"trials":211,"activeCount":63},[],{"intervention":152,"totalTrials":59,"cells":213},{"EARLY_PHASE1":214,"PHASE1":216,"PHASE2":218,"PHASE3":220,"PHASE4":222,"NA":228},{"trials":215,"activeCount":63},[],{"trials":217,"activeCount":63},[],{"trials":219,"activeCount":63},[],{"trials":221,"activeCount":63},[],{"trials":223,"activeCount":63},[224],{"nctId":142,"briefTitle":143,"status":144,"phases":225,"primaryCompletion":146,"completion":147,"start":148,"enrollment":63,"conditions":226,"interventions":227},[55],[150],[152,128],{"trials":229,"activeCount":63},[],{"intervention":231,"totalTrials":59,"cells":232},"Praziquantel",{"EARLY_PHASE1":233,"PHASE1":235,"PHASE2":237,"PHASE3":239,"PHASE4":241,"NA":255},{"trials":234,"activeCount":63},[],{"trials":236,"activeCount":63},[],{"trials":238,"activeCount":63},[],{"trials":240,"activeCount":63},[],{"trials":242,"activeCount":63},[243],{"nctId":244,"briefTitle":245,"status":246,"phases":247,"primaryCompletion":248,"completion":248,"start":249,"enrollment":250,"conditions":251,"interventions":254},"NCT02878564","Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology","COMPLETED",[55],"2016-10","2016-03",34,[252,253],"Schistosomiasis Mansoni","HIV",[231],{"trials":256,"activeCount":63},[],{"intervention":163,"totalTrials":59,"cells":258},{"EARLY_PHASE1":259,"PHASE1":261,"PHASE2":263,"PHASE3":265,"PHASE4":267,"NA":273},{"trials":260,"activeCount":63},[],{"trials":262,"activeCount":63},[],{"trials":264,"activeCount":63},[],{"trials":266,"activeCount":63},[],{"trials":268,"activeCount":63},[269],{"nctId":154,"briefTitle":155,"status":144,"phases":270,"primaryCompletion":157,"completion":158,"start":159,"enrollment":63,"conditions":271,"interventions":272},[55],[161],[163,128],{"trials":274,"activeCount":63},[],{"intervention":276,"totalTrials":59,"cells":277},"Live-attenuated varicella-zoster virus vaccine",{"EARLY_PHASE1":278,"PHASE1":280,"PHASE2":282,"PHASE3":284,"PHASE4":286,"NA":298},{"trials":279,"activeCount":63},[],{"trials":281,"activeCount":63},[],{"trials":283,"activeCount":63},[],{"trials":285,"activeCount":63},[],{"trials":287,"activeCount":63},[288],{"nctId":289,"briefTitle":290,"status":182,"phases":291,"primaryCompletion":292,"completion":293,"start":294,"enrollment":295,"conditions":296,"interventions":297},"NCT02514018","Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine",[55],"2017-01","2017-07","2015-09",45,[26],[276],{"trials":299,"activeCount":63},[],{"intervention":301,"totalTrials":59,"cells":302},"vitamin C & E supplements",{"EARLY_PHASE1":303,"PHASE1":305,"PHASE2":307,"PHASE3":309,"PHASE4":311,"NA":323},{"trials":304,"activeCount":63},[],{"trials":306,"activeCount":63},[],{"trials":308,"activeCount":63},[],{"trials":310,"activeCount":63},[],{"trials":312,"activeCount":63},[313],{"nctId":314,"briefTitle":315,"status":182,"phases":316,"completion":317,"start":318,"enrollment":319,"conditions":320,"interventions":322},"NCT00303160","Effect of Helicobacter Pylori on the Availability of Vitamin E and C",[55],"2007-09","2006-03",72,[321],"Heliobacter Pylori Infection",[301],{"trials":324,"activeCount":63},[],{"intervention":326,"totalTrials":59,"cells":327},"MuscleCare Topical Product",{"EARLY_PHASE1":328,"PHASE1":330,"PHASE2":332,"PHASE3":334,"PHASE4":336,"NA":350},{"trials":329,"activeCount":63},[],{"trials":331,"activeCount":63},[],{"trials":333,"activeCount":63},[],{"trials":335,"activeCount":63},[],{"trials":337,"activeCount":63},[338],{"nctId":339,"briefTitle":340,"status":246,"phases":341,"primaryCompletion":342,"completion":342,"start":343,"enrollment":344,"conditions":345,"interventions":347},"NCT03939884","MuscleCare™ Pain Relief Therapy vs. Voltaren® in the Relief of Trapezius Trigger Point Musculoskeletal Pain.",[55],"2018-02-25","2017-03-28",120,[346],"Pain",[326,348,349],"Voltaren Topical","Nivea, Topical Cream",{"trials":351,"activeCount":63},[],{"intervention":348,"totalTrials":59,"cells":353},{"EARLY_PHASE1":354,"PHASE1":356,"PHASE2":358,"PHASE3":360,"PHASE4":362,"NA":368},{"trials":355,"activeCount":63},[],{"trials":357,"activeCount":63},[],{"trials":359,"activeCount":63},[],{"trials":361,"activeCount":63},[],{"trials":363,"activeCount":63},[364],{"nctId":339,"briefTitle":340,"status":246,"phases":365,"primaryCompletion":342,"completion":342,"start":343,"enrollment":344,"conditions":366,"interventions":367},[55],[346],[326,348,349],{"trials":369,"activeCount":63},[],{"intervention":349,"totalTrials":59,"cells":371},{"EARLY_PHASE1":372,"PHASE1":374,"PHASE2":376,"PHASE3":378,"PHASE4":380,"NA":386},{"trials":373,"activeCount":63},[],{"trials":375,"activeCount":63},[],{"trials":377,"activeCount":63},[],{"trials":379,"activeCount":63},[],{"trials":381,"activeCount":63},[382],{"nctId":339,"briefTitle":340,"status":246,"phases":383,"primaryCompletion":342,"completion":342,"start":343,"enrollment":344,"conditions":384,"interventions":385},[55],[346],[326,348,349],{"trials":387,"activeCount":63},[],{"intervention":389,"totalTrials":59,"cells":390},"Nitroglycerin ointment 15 mg\u002Fday daily for 24 month",{"EARLY_PHASE1":391,"PHASE1":393,"PHASE2":395,"PHASE3":397,"PHASE4":410,"NA":412},{"trials":392,"activeCount":63},[],{"trials":394,"activeCount":63},[],{"trials":396,"activeCount":63},[],{"trials":398,"activeCount":63},[399],{"nctId":400,"briefTitle":401,"status":246,"phases":402,"primaryCompletion":403,"completion":404,"start":405,"enrollment":406,"conditions":407,"interventions":409},"NCT00252421","The Nitrate and Bone Study: Effects of Nitrates on Osteoporosis",[54],"2010-06","2010-07","2005-10",243,[408],"Osteoporosis",[389],{"trials":411,"activeCount":63},[],{"trials":413,"activeCount":63},[],{"intervention":415,"totalTrials":59,"cells":416},"Fluoride varnish",{"EARLY_PHASE1":417,"PHASE1":419,"PHASE2":421,"PHASE3":423,"PHASE4":435,"NA":437},{"trials":418,"activeCount":63},[],{"trials":420,"activeCount":63},[],{"trials":422,"activeCount":63},[],{"trials":424,"activeCount":63},[425],{"nctId":426,"briefTitle":427,"status":182,"phases":428,"completion":429,"start":430,"enrollment":431,"conditions":432,"interventions":434},"NCT00435500","Fluoride Varnish in the Prevention of Dental Caries in Aboriginal and Non-aboriginal Children",[54],"2006-01","2003-06",1320,[433],"Dental Caries",[415],{"trials":436,"activeCount":63},[],{"trials":438,"activeCount":63},[],{"intervention":440,"totalTrials":59,"cells":441},"Nitrates",{"EARLY_PHASE1":442,"PHASE1":444,"PHASE2":446,"PHASE3":448,"PHASE4":459,"NA":461},{"trials":443,"activeCount":63},[],{"trials":445,"activeCount":63},[],{"trials":447,"activeCount":63},[],{"trials":449,"activeCount":63},[450],{"nctId":451,"briefTitle":452,"status":246,"phases":453,"primaryCompletion":454,"completion":454,"start":455,"enrollment":456,"conditions":457,"interventions":458},"NCT01387672","Nitrates and Bone Turnover; Nitrates and Bone Turnover Bisphosphonate Sub-Study",[54],"2014-12","2011-09",265,[408],[440],{"trials":460,"activeCount":63},[],{"trials":462,"activeCount":63},[],{"intervention":464,"totalTrials":59,"cells":465},"Atorvastatin",{"EARLY_PHASE1":466,"PHASE1":468,"PHASE2":470,"PHASE3":472,"PHASE4":488,"NA":490},{"trials":467,"activeCount":63},[],{"trials":469,"activeCount":63},[],{"trials":471,"activeCount":63},[],{"trials":473,"activeCount":63},[474],{"nctId":475,"briefTitle":476,"status":182,"phases":477,"completion":478,"start":479,"enrollment":480,"conditions":481,"interventions":487},"NCT00517257","Atorvastatin for the Treatment of Retinal Vein Occlusion",[54],"2009-09","2007-08",180,[482,483,484,485,486],"Retinal Vein Occlusion","Retinal Vein Thrombosis","Central Retinal Vein Occlusion","Branch Retinal Vein Occlusion","Thrombosis",[464],{"trials":489,"activeCount":63},[],{"trials":491,"activeCount":63},[],{"intervention":493,"totalTrials":59,"cells":494},"Alcohol",{"EARLY_PHASE1":495,"PHASE1":497,"PHASE2":499,"PHASE3":501,"PHASE4":514,"NA":516},{"trials":496,"activeCount":63},[],{"trials":498,"activeCount":63},[],{"trials":500,"activeCount":63},[],{"trials":502,"activeCount":63},[503],{"nctId":504,"briefTitle":505,"status":182,"phases":506,"primaryCompletion":507,"completion":507,"start":508,"enrollment":509,"conditions":510,"interventions":512},"NCT03131843","Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination",[54],"2018-12","2017-05-01",170,[511],"Skin Infection",[493,513],"No alcohol",{"trials":515,"activeCount":63},[],{"trials":517,"activeCount":63},[],{"intervention":513,"totalTrials":59,"cells":519},{"EARLY_PHASE1":520,"PHASE1":522,"PHASE2":524,"PHASE3":526,"PHASE4":532,"NA":534},{"trials":521,"activeCount":63},[],{"trials":523,"activeCount":63},[],{"trials":525,"activeCount":63},[],{"trials":527,"activeCount":63},[528],{"nctId":504,"briefTitle":505,"status":182,"phases":529,"primaryCompletion":507,"completion":507,"start":508,"enrollment":509,"conditions":530,"interventions":531},[54],[511],[493,513],{"trials":533,"activeCount":63},[],{"trials":535,"activeCount":63},[],{"intervention":537,"totalTrials":59,"cells":538},"1% lidocaine with 1:100,000 adrenaline",{"EARLY_PHASE1":539,"PHASE1":541,"PHASE2":543,"PHASE3":545,"PHASE4":558,"NA":560},{"trials":540,"activeCount":63},[],{"trials":542,"activeCount":63},[],{"trials":544,"activeCount":63},[],{"trials":546,"activeCount":63},[547],{"nctId":548,"briefTitle":549,"status":182,"phases":550,"primaryCompletion":551,"completion":551,"start":552,"enrollment":553,"conditions":554,"interventions":556},"NCT00852410","The Hemostatic and Hemodynamic Effects of Adrenaline During Endoscopic Sinus Surgery",[54],"2010-04","2009-03",140,[555],"Chronic Sinusitis",[537,557],"1% lidocaine with 1:200,000 adrenaline",{"trials":559,"activeCount":63},[],{"trials":561,"activeCount":63},[],{"intervention":557,"totalTrials":59,"cells":563},{"EARLY_PHASE1":564,"PHASE1":566,"PHASE2":568,"PHASE3":570,"PHASE4":576,"NA":578},{"trials":565,"activeCount":63},[],{"trials":567,"activeCount":63},[],{"trials":569,"activeCount":63},[],{"trials":571,"activeCount":63},[572],{"nctId":548,"briefTitle":549,"status":182,"phases":573,"primaryCompletion":551,"completion":551,"start":552,"enrollment":553,"conditions":574,"interventions":575},[54],[555],[537,557],{"trials":577,"activeCount":63},[],{"trials":579,"activeCount":63},[],{"intervention":581,"totalTrials":59,"cells":582},"raltegravir",{"EARLY_PHASE1":583,"PHASE1":585,"PHASE2":587,"PHASE3":589,"PHASE4":604,"NA":606},{"trials":584,"activeCount":63},[],{"trials":586,"activeCount":63},[],{"trials":588,"activeCount":63},[],{"trials":590,"activeCount":63},[591],{"nctId":592,"briefTitle":593,"status":246,"phases":594,"primaryCompletion":595,"completion":595,"start":596,"enrollment":597,"conditions":598,"interventions":600},"NCT01154673","Effects of Intensive cART During Acute\u002FEarly HIV Infection",[53,54],"2014-09","2011-11",32,[599],"Acute HIV Infection",[581,601,602,603],"maraviroc","emtricitabine 200mg \u002Ftenofovir 300mg","lopinavir 400 mg\u002Fritonavir 100mg",{"trials":605,"activeCount":63},[],{"trials":607,"activeCount":63},[],{"intervention":601,"totalTrials":59,"cells":609},{"EARLY_PHASE1":610,"PHASE1":612,"PHASE2":614,"PHASE3":616,"PHASE4":622,"NA":624},{"trials":611,"activeCount":63},[],{"trials":613,"activeCount":63},[],{"trials":615,"activeCount":63},[],{"trials":617,"activeCount":63},[618],{"nctId":592,"briefTitle":593,"status":246,"phases":619,"primaryCompletion":595,"completion":595,"start":596,"enrollment":597,"conditions":620,"interventions":621},[53,54],[599],[581,601,602,603],{"trials":623,"activeCount":63},[],{"trials":625,"activeCount":63},[],{"intervention":602,"totalTrials":59,"cells":627},{"EARLY_PHASE1":628,"PHASE1":630,"PHASE2":632,"PHASE3":634,"PHASE4":640,"NA":642},{"trials":629,"activeCount":63},[],{"trials":631,"activeCount":63},[],{"trials":633,"activeCount":63},[],{"trials":635,"activeCount":63},[636],{"nctId":592,"briefTitle":593,"status":246,"phases":637,"primaryCompletion":595,"completion":595,"start":596,"enrollment":597,"conditions":638,"interventions":639},[53,54],[599],[581,601,602,603],{"trials":641,"activeCount":63},[],{"trials":643,"activeCount":63},[],{"intervention":603,"totalTrials":59,"cells":645},{"EARLY_PHASE1":646,"PHASE1":648,"PHASE2":650,"PHASE3":652,"PHASE4":658,"NA":660},{"trials":647,"activeCount":63},[],{"trials":649,"activeCount":63},[],{"trials":651,"activeCount":63},[],{"trials":653,"activeCount":63},[654],{"nctId":592,"briefTitle":593,"status":246,"phases":655,"primaryCompletion":595,"completion":595,"start":596,"enrollment":597,"conditions":656,"interventions":657},[53,54],[599],[581,601,602,603],{"trials":659,"activeCount":63},[],{"trials":661,"activeCount":63},[],{"intervention":663,"totalTrials":59,"cells":664},"pregabalin",{"EARLY_PHASE1":665,"PHASE1":667,"PHASE2":669,"PHASE3":682,"PHASE4":684,"NA":686},{"trials":666,"activeCount":63},[],{"trials":668,"activeCount":63},[],{"trials":670,"activeCount":63},[671],{"nctId":672,"briefTitle":673,"status":674,"phases":675,"primaryCompletion":676,"completion":676,"start":677,"enrollment":59,"conditions":678,"interventions":681},"NCT00852436","Pregabalin and Orofacial Neuropathic Pain","TERMINATED",[53],"2010-10","2009-02",[679,680],"Neuropathic Pain","Orofacial Pain",[663],{"trials":683,"activeCount":63},[],{"trials":685,"activeCount":63},[],{"trials":687,"activeCount":63},[],{"intervention":689,"totalTrials":59,"cells":690},"High Fructose Corn Syrup",{"EARLY_PHASE1":691,"PHASE1":693,"PHASE2":695,"PHASE3":708,"PHASE4":710,"NA":712},{"trials":692,"activeCount":63},[],{"trials":694,"activeCount":63},[],{"trials":696,"activeCount":63},[697],{"nctId":698,"briefTitle":699,"status":246,"phases":700,"completion":701,"start":702,"enrollment":703,"conditions":704,"interventions":706},"NCT00374218","Effect of Replacing HFCS With Sucromalt in Subjects With Raised Waist Circumference",[53],"2007-04","2006-09",28,[705],"Abdominal Obesity",[689,707],"Sucromalt",{"trials":709,"activeCount":63},[],{"trials":711,"activeCount":63},[],{"trials":713,"activeCount":63},[],{"intervention":707,"totalTrials":59,"cells":715},{"EARLY_PHASE1":716,"PHASE1":718,"PHASE2":720,"PHASE3":726,"PHASE4":728,"NA":730},{"trials":717,"activeCount":63},[],{"trials":719,"activeCount":63},[],{"trials":721,"activeCount":63},[722],{"nctId":698,"briefTitle":699,"status":246,"phases":723,"completion":701,"start":702,"enrollment":703,"conditions":724,"interventions":725},[53],[705],[689,707],{"trials":727,"activeCount":63},[],{"trials":729,"activeCount":63},[],{"trials":731,"activeCount":63},[],{"intervention":733,"totalTrials":59,"cells":734},"L-dopa",{"EARLY_PHASE1":735,"PHASE1":737,"PHASE2":739,"PHASE3":752,"PHASE4":754,"NA":756},{"trials":736,"activeCount":63},[],{"trials":738,"activeCount":63},[],{"trials":740,"activeCount":63},[741],{"nctId":742,"briefTitle":743,"status":182,"phases":744,"primaryCompletion":745,"completion":745,"start":746,"enrollment":747,"conditions":748,"interventions":750},"NCT02347059","L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease",[53],"2016-08","2015-01",40,[749],"Parkinson's Disease",[733,751],"Dopamine Agonists",{"trials":753,"activeCount":63},[],{"trials":755,"activeCount":63},[],{"trials":757,"activeCount":63},[],{"intervention":751,"totalTrials":59,"cells":759},{"EARLY_PHASE1":760,"PHASE1":762,"PHASE2":764,"PHASE3":770,"PHASE4":772,"NA":774},{"trials":761,"activeCount":63},[],{"trials":763,"activeCount":63},[],{"trials":765,"activeCount":63},[766],{"nctId":742,"briefTitle":743,"status":182,"phases":767,"primaryCompletion":745,"completion":745,"start":746,"enrollment":747,"conditions":768,"interventions":769},[53],[749],[733,751],{"trials":771,"activeCount":63},[],{"trials":773,"activeCount":63},[],{"trials":775,"activeCount":63},[],{"intervention":777,"totalTrials":59,"cells":778},"lactose\u002Fsucrose granule",{"EARLY_PHASE1":779,"PHASE1":781,"PHASE2":783,"PHASE3":796,"PHASE4":798,"NA":800},{"trials":780,"activeCount":63},[],{"trials":782,"activeCount":63},[],{"trials":784,"activeCount":63},[785],{"nctId":786,"briefTitle":787,"status":246,"phases":788,"primaryCompletion":789,"completion":790,"start":791,"enrollment":792,"conditions":793,"interventions":795},"NCT02086864","A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD",[53],"2021-03","2023-08","2014-03",151,[794],"Attention Deficit Hyperactivity Disorder",[777],{"trials":797,"activeCount":63},[],{"trials":799,"activeCount":63},[],{"trials":801,"activeCount":63},[],{"intervention":803,"totalTrials":59,"cells":804},"Metronidazole",{"EARLY_PHASE1":805,"PHASE1":807,"PHASE2":819,"PHASE3":821,"PHASE4":823,"NA":825},{"trials":806,"activeCount":63},[],{"trials":808,"activeCount":63},[809],{"nctId":810,"briefTitle":811,"status":246,"phases":812,"primaryCompletion":813,"completion":813,"start":814,"enrollment":75,"conditions":815,"interventions":818},"NCT02527941","Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology",[52],"2015-11","2015-08",[816,817],"Bacterial Vaginosis","HIV Infections",[803],{"trials":820,"activeCount":63},[],{"trials":822,"activeCount":63},[],{"trials":824,"activeCount":63},[],{"trials":826,"activeCount":63},[],{"intervention":828,"totalTrials":59,"cells":829},"Oral Tinidazole",{"EARLY_PHASE1":830,"PHASE1":832,"PHASE2":834,"PHASE3":836,"PHASE4":838,"NA":840},{"trials":831,"activeCount":63},[],{"trials":833,"activeCount":63},[],{"trials":835,"activeCount":63},[],{"trials":837,"activeCount":63},[],{"trials":839,"activeCount":63},[],{"trials":841,"activeCount":63},[842],{"nctId":843,"briefTitle":844,"status":182,"phases":845,"primaryCompletion":846,"completion":846,"start":847,"enrollment":848,"conditions":849,"interventions":851},"NCT03412071","Effect of Antibiotics on Penile Microbiome and HIV Susceptibility Study in Ugandan Men",[56],"2019-12-07","2017-12-07",125,[850],"Foreskin HIV Susceptibility",[828,852,853,854],"Topical metronidazole","Topical Clindamycin","Topical Hydrogen Peroxide",{"intervention":852,"totalTrials":59,"cells":856},{"EARLY_PHASE1":857,"PHASE1":859,"PHASE2":861,"PHASE3":863,"PHASE4":865,"NA":867},{"trials":858,"activeCount":63},[],{"trials":860,"activeCount":63},[],{"trials":862,"activeCount":63},[],{"trials":864,"activeCount":63},[],{"trials":866,"activeCount":63},[],{"trials":868,"activeCount":63},[869],{"nctId":843,"briefTitle":844,"status":182,"phases":870,"primaryCompletion":846,"completion":846,"start":847,"enrollment":848,"conditions":871,"interventions":872},[56],[850],[828,852,853,854],{"intervention":853,"totalTrials":59,"cells":874},{"EARLY_PHASE1":875,"PHASE1":877,"PHASE2":879,"PHASE3":881,"PHASE4":883,"NA":885},{"trials":876,"activeCount":63},[],{"trials":878,"activeCount":63},[],{"trials":880,"activeCount":63},[],{"trials":882,"activeCount":63},[],{"trials":884,"activeCount":63},[],{"trials":886,"activeCount":63},[887],{"nctId":843,"briefTitle":844,"status":182,"phases":888,"primaryCompletion":846,"completion":846,"start":847,"enrollment":848,"conditions":889,"interventions":890},[56],[850],[828,852,853,854],{"intervention":854,"totalTrials":59,"cells":892},{"EARLY_PHASE1":893,"PHASE1":895,"PHASE2":897,"PHASE3":899,"PHASE4":901,"NA":903},{"trials":894,"activeCount":63},[],{"trials":896,"activeCount":63},[],{"trials":898,"activeCount":63},[],{"trials":900,"activeCount":63},[],{"trials":902,"activeCount":63},[],{"trials":904,"activeCount":63},[905],{"nctId":843,"briefTitle":844,"status":182,"phases":906,"primaryCompletion":846,"completion":846,"start":847,"enrollment":848,"conditions":907,"interventions":908},[56],[850],[828,852,853,854],{"intervention":910,"totalTrials":59,"cells":911},"Valacyclovir",{"EARLY_PHASE1":912,"PHASE1":914,"PHASE2":916,"PHASE3":918,"PHASE4":920,"NA":922},{"trials":913,"activeCount":63},[],{"trials":915,"activeCount":63},[],{"trials":917,"activeCount":63},[],{"trials":919,"activeCount":63},[],{"trials":921,"activeCount":63},[],{"trials":923,"activeCount":63},[924],{"nctId":925,"briefTitle":926,"status":246,"phases":927,"primaryCompletion":928,"completion":928,"start":551,"enrollment":929,"conditions":930,"interventions":932},"NCT00946556","Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix",[56],"2011-05",30,[931,817],"Herpes Simplex Type Two Infection",[910],{"intervention":934,"totalTrials":59,"cells":935},"Low fibre breakfast cereal",{"EARLY_PHASE1":936,"PHASE1":938,"PHASE2":940,"PHASE3":942,"PHASE4":944,"NA":946},{"trials":937,"activeCount":63},[],{"trials":939,"activeCount":63},[],{"trials":941,"activeCount":63},[],{"trials":943,"activeCount":63},[],{"trials":945,"activeCount":63},[],{"trials":947,"activeCount":63},[948],{"nctId":949,"briefTitle":950,"status":246,"phases":951,"completion":952,"start":953,"enrollment":597,"conditions":954,"interventions":955},"NCT00247455","Fibre and Appetite Regulation Trial (FART)",[56],"2005-08","2002-03",[17,20],[934,956],"High fibre cereal",{"intervention":956,"totalTrials":59,"cells":958},{"EARLY_PHASE1":959,"PHASE1":961,"PHASE2":963,"PHASE3":965,"PHASE4":967,"NA":969},{"trials":960,"activeCount":63},[],{"trials":962,"activeCount":63},[],{"trials":964,"activeCount":63},[],{"trials":966,"activeCount":63},[],{"trials":968,"activeCount":63},[],{"trials":970,"activeCount":63},[971],{"nctId":949,"briefTitle":950,"status":246,"phases":972,"completion":952,"start":953,"enrollment":597,"conditions":973,"interventions":974},[56],[17,20],[934,956],{"intervention":976,"totalTrials":59,"cells":977},"NuvaRing",{"EARLY_PHASE1":978,"PHASE1":980,"PHASE2":982,"PHASE3":984,"PHASE4":986,"NA":988},{"trials":979,"activeCount":63},[],{"trials":981,"activeCount":63},[],{"trials":983,"activeCount":63},[],{"trials":985,"activeCount":63},[],{"trials":987,"activeCount":63},[],{"trials":989,"activeCount":63},[990],{"nctId":991,"briefTitle":992,"status":674,"phases":993,"primaryCompletion":994,"completion":995,"start":996,"enrollment":997,"conditions":998,"interventions":1001},"NCT01298128","NuvaRing vs. Oral Contraceptive Pills (OCP) for In-Vitro Fertilization (IVF) Pre-treatment",[56],"2010-03","2010-12","2006-02",70,[999,1000],"Infertility","In-vitro Fertilization",[976,1002],"marvelon",{"intervention":1002,"totalTrials":59,"cells":1004},{"EARLY_PHASE1":1005,"PHASE1":1007,"PHASE2":1009,"PHASE3":1011,"PHASE4":1013,"NA":1015},{"trials":1006,"activeCount":63},[],{"trials":1008,"activeCount":63},[],{"trials":1010,"activeCount":63},[],{"trials":1012,"activeCount":63},[],{"trials":1014,"activeCount":63},[],{"trials":1016,"activeCount":63},[1017],{"nctId":991,"briefTitle":992,"status":674,"phases":1018,"primaryCompletion":994,"completion":995,"start":996,"enrollment":997,"conditions":1019,"interventions":1020},[56],[999,1000],[976,1002],{"intervention":1022,"totalTrials":59,"cells":1023},"topical brimonidine tartrate 0.15%",{"EARLY_PHASE1":1024,"PHASE1":1026,"PHASE2":1028,"PHASE3":1030,"PHASE4":1032,"NA":1034},{"trials":1025,"activeCount":63},[],{"trials":1027,"activeCount":63},[],{"trials":1029,"activeCount":63},[],{"trials":1031,"activeCount":63},[],{"trials":1033,"activeCount":63},[],{"trials":1035,"activeCount":63},[1036],{"nctId":1037,"briefTitle":1038,"status":246,"phases":1039,"primaryCompletion":1040,"completion":1041,"start":1042,"enrollment":1043,"conditions":1044,"interventions":1046},"NCT03513172","Pre-Administration of Brimonidine in Intravitreal Anti-VEGF Therapy",[56],"2017-07-15","2017-09-01","2016-12-15",55,[1045],"Post-Injection Intraocular Pressure Spikes",[1022],{"intervention":1048,"totalTrials":59,"cells":1049},"acetaminophen",{"EARLY_PHASE1":1050,"PHASE1":1052,"PHASE2":1054,"PHASE3":1056,"PHASE4":1058,"NA":1060},{"trials":1051,"activeCount":63},[],{"trials":1053,"activeCount":63},[],{"trials":1055,"activeCount":63},[],{"trials":1057,"activeCount":63},[],{"trials":1059,"activeCount":63},[],{"trials":1061,"activeCount":63},[1062],{"nctId":1063,"briefTitle":1064,"status":246,"phases":1065,"primaryCompletion":1066,"completion":1066,"start":1067,"enrollment":1068,"conditions":1069,"interventions":1071},"NCT00561288","Effects of Acetaminophen on Hurt Feelings",[56],"2008-05","2007-11",60,[1070],"Emotional Pain",[1048],{"intervention":1073,"totalTrials":59,"cells":1074},"Continuous adductor canal block",{"EARLY_PHASE1":1075,"PHASE1":1077,"PHASE2":1079,"PHASE3":1081,"PHASE4":1083,"NA":1085},{"trials":1076,"activeCount":63},[],{"trials":1078,"activeCount":63},[],{"trials":1080,"activeCount":63},[],{"trials":1082,"activeCount":63},[],{"trials":1084,"activeCount":63},[],{"trials":1086,"activeCount":63},[1087],{"nctId":1088,"briefTitle":1089,"status":246,"phases":1090,"primaryCompletion":1091,"completion":1092,"start":1093,"enrollment":1068,"conditions":1094,"interventions":1098},"NCT05100706","Continuous Adductor Canal Block in Outpatient Total Knee Arthroplasty",[56],"2025-01-06","2025-06-30","2023-10-01",[1095,1096,1097],"Knee Arthroplasty, Total","Anesthesia, Regional","Acute Pain",[1073,1099],"Sham continuous adductor canal block (ShACB).",{"intervention":1099,"totalTrials":59,"cells":1101},{"EARLY_PHASE1":1102,"PHASE1":1104,"PHASE2":1106,"PHASE3":1108,"PHASE4":1110,"NA":1112},{"trials":1103,"activeCount":63},[],{"trials":1105,"activeCount":63},[],{"trials":1107,"activeCount":63},[],{"trials":1109,"activeCount":63},[],{"trials":1111,"activeCount":63},[],{"trials":1113,"activeCount":63},[1114],{"nctId":1088,"briefTitle":1089,"status":246,"phases":1115,"primaryCompletion":1091,"completion":1092,"start":1093,"enrollment":1068,"conditions":1116,"interventions":1117},[56],[1095,1096,1097],[1073,1099],{"intervention":1119,"totalTrials":59,"cells":1120},"Control - high carbohydrate, high glycemic index foods",{"EARLY_PHASE1":1121,"PHASE1":1123,"PHASE2":1125,"PHASE3":1127,"PHASE4":1129,"NA":1131},{"trials":1122,"activeCount":63},[],{"trials":1124,"activeCount":63},[],{"trials":1126,"activeCount":63},[],{"trials":1128,"activeCount":63},[],{"trials":1130,"activeCount":63},[],{"trials":1132,"activeCount":63},[1133],{"nctId":1134,"briefTitle":1135,"status":246,"phases":1136,"completion":1137,"start":1138,"enrollment":1139,"conditions":1140,"interventions":1141},"NCT00223574","Canadian Trial of Dietary Carbohydrates in Diabetes",[56],"2004-10","2002-01",168,[35],[1119,1142,1143],"high carbohydrate, low glycemic index foods","low carbohydrate, high monounsaturate fat foods",{"intervention":1142,"totalTrials":59,"cells":1145},{"EARLY_PHASE1":1146,"PHASE1":1148,"PHASE2":1150,"PHASE3":1152,"PHASE4":1154,"NA":1156},{"trials":1147,"activeCount":63},[],{"trials":1149,"activeCount":63},[],{"trials":1151,"activeCount":63},[],{"trials":1153,"activeCount":63},[],{"trials":1155,"activeCount":63},[],{"trials":1157,"activeCount":63},[1158],{"nctId":1134,"briefTitle":1135,"status":246,"phases":1159,"completion":1137,"start":1138,"enrollment":1139,"conditions":1160,"interventions":1161},[56],[35],[1119,1142,1143],{"intervention":1143,"totalTrials":59,"cells":1163},{"EARLY_PHASE1":1164,"PHASE1":1166,"PHASE2":1168,"PHASE3":1170,"PHASE4":1172,"NA":1174},{"trials":1165,"activeCount":63},[],{"trials":1167,"activeCount":63},[],{"trials":1169,"activeCount":63},[],{"trials":1171,"activeCount":63},[],{"trials":1173,"activeCount":63},[],{"trials":1175,"activeCount":63},[1176],{"nctId":1134,"briefTitle":1135,"status":246,"phases":1177,"completion":1137,"start":1138,"enrollment":1139,"conditions":1178,"interventions":1179},[56],[35],[1119,1142,1143],{"intervention":1181,"totalTrials":59,"cells":1182},"lidocaine topical",{"EARLY_PHASE1":1183,"PHASE1":1185,"PHASE2":1187,"PHASE3":1189,"PHASE4":1191,"NA":1193},{"trials":1184,"activeCount":63},[],{"trials":1186,"activeCount":63},[],{"trials":1188,"activeCount":63},[],{"trials":1190,"activeCount":63},[],{"trials":1192,"activeCount":63},[],{"trials":1194,"activeCount":63},[1195],{"nctId":1196,"briefTitle":1197,"status":182,"phases":1198,"completion":1199,"start":1200,"enrollment":1201,"conditions":1202,"interventions":1203},"NCT00353041","A Study of the Effect of Time on Topical Anesthetic Efficacy.",[56],"2006-12","2006-07",90,[346],[1181]]